GSK Investigational Site

Trento, Trentino-Alto Adige 38100

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms, Breast

Studies at this site

• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer — Stopped early